MA40818A1 - Improved administration of viral particles to striatum and cortex - Google Patents

Improved administration of viral particles to striatum and cortex

Info

Publication number
MA40818A1
MA40818A1 MA40818A MA40818A MA40818A1 MA 40818 A1 MA40818 A1 MA 40818A1 MA 40818 A MA40818 A MA 40818A MA 40818 A MA40818 A MA 40818A MA 40818 A1 MA40818 A1 MA 40818A1
Authority
MA
Morocco
Prior art keywords
striatum
viral particles
cortex
nucleic acid
improved administration
Prior art date
Application number
MA40818A
Other languages
French (fr)
Other versions
MA40818B2 (en
Inventor
Lamya Shihabuddin
Lisa Stanek
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Priority claimed from PCT/US2016/017210 external-priority patent/WO2016130591A2/en
Publication of MA40818A1 publication Critical patent/MA40818A1/en
Publication of MA40818B2 publication Critical patent/MA40818B2/en

Links

Abstract

La présente invention concerne de nouveaux procédés d'administration de particules virales adéno-associées recombinées (raav) au système nerveux central d'un mammifère (p. Ex., l'homme). Selon certains aspects, les procédés impliquent l'administration des particules raav contenant un acide nucléique hétérologue au striatum et l'induction de l'expression de l'acide nucléique hétérologue dans au moins le cortex cérébral et le striatum du mammifère.The present invention provides novel methods of administering recombinant adeno-associated viral particles (raav) to the central nervous system of a mammal (e.g., humans). In some aspects, the methods involve administering raav particles containing striatal heterologous nucleic acid and inducing expression of the heterologous nucleic acid in at least the mammalian cerebral cortex and striatum.

MA40818A 2015-02-10 2016-02-09 Improved delivery of viral particles to the striatum and cortex MA40818B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562114544P 2015-02-10 2015-02-10
PCT/US2016/017210 WO2016130591A2 (en) 2015-02-10 2016-02-09 Enhanced delivery of viral particles to the striatum and cortex

Publications (2)

Publication Number Publication Date
MA40818A1 true MA40818A1 (en) 2018-01-31
MA40818B2 MA40818B2 (en) 2022-04-29

Family

ID=61730514

Family Applications (1)

Application Number Title Priority Date Filing Date
MA40818A MA40818B2 (en) 2015-02-10 2016-02-09 Improved delivery of viral particles to the striatum and cortex

Country Status (2)

Country Link
HR (1) HRP20220042T1 (en)
MA (1) MA40818B2 (en)

Also Published As

Publication number Publication date
HRP20220042T1 (en) 2022-04-01
MA40818B2 (en) 2022-04-29

Similar Documents

Publication Publication Date Title
TN2017000353A1 (en) Enhanced delivery of viral particles to the striatum and cortex
PH12020550094A1 (en) Adeno-associated virus variant capsids and methods of use thereof
PH12018500594A1 (en) Adeno-associated virus factor viii vectors, associated viral particles and therapeutic formulations comprising the same
MA39390A1 (en) Gene therapy for the treatment of retinitis pigmentosa
PH12018502387A1 (en) Adeno-associated virus variant capsids and methods of use thereof
MA51353B1 (en) Hybrid recombinant adeno-associated virus serotype between aav9 and aavrh74 with reduced hepatic tropism
EA202090817A1 (en) TRISSPECIFIC PROTEINS AND METHODS OF THEIR APPLICATION
MA44059B1 (en) Human immunodeficiency virus antigens, vectors, compositions, and methods of use thereof
WO2017058892A3 (en) Methods and compositions for antibody-evading virus vectors
MX2018002068A (en) Purification of fkpa and uses thereof for producing recombinant polypeptides.
EA202090738A1 (en) METHOD FOR SAFE INDUCING IMMUNITY AGAINST RSV
IN2014MN01781A (en)
MA43113A (en) ANTI-HTR A1 ANTIBODIES AND METHODS OF USING THEM
Garcia et al. Superior isolation of antigen-specific brain infiltrating T cells using manual homogenization technique
ES2626595T5 (en) IFN-lambda production by conventional dendritic cells and their uses
EA202191280A1 (en) DELIVERY CONSTRUCTS FOR TRANSCYTOSIS AND RELATED METHODS
MA39096B1 (en) Antibodies specific to fcrn
Boura et al. Evaluation of gene delivery strategies to efficiently overexpress functional HLA-G on human bone marrow stromal cells
MA37749B1 (en) Vaccines against bluetongue and African horse sickness virus
Abboud et al. Transcription factor Bcl11b controls effector and memory CD8 T cell fate decision and function during poxvirus infection
MA40818A1 (en) Improved administration of viral particles to striatum and cortex
Duan et al. Bidirectional factors impact the migration of NK cells to draining lymph node in aged mice during influenza virus infection
MA40844A (en) LONG-ACTING PHARMACEUTICAL COMPOSITIONS FOR HEPATITIS C
MA40817A (en) LONG-ACTION COMBINATION COMPOSITIONS AND METHODS FOR CONTROLLING HEPATITIS C
MX2016015574A (en) Purified compositions of ivig and kh proteins for modulating lymphocytes and treating hepatitis b virus.